Psychedelic Stocks Surge Up to 40% After Trump Executive Order on Mental Health Drugs
Shares in psychedelic drug companies jumped as much as 40% after President Trump signed an executive order aimed at accelerating the regulatory approval process for psychedelic treatments such as LSD for mental illness.
რეკლამა: Article Inline